Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalie Ives

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Trials|June 9, 2014
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trialCatherine M Sackley, Christina H Smith, Caroline Rick, et al.
Health Technology Assessment (Winchester, England)|August 12, 2021
Practice nurse-supported weight self-management delivered within the national child immunisation programme for postnatal women: a feasibility cluster RCTAmanda J Daley, Kate Jolly, Natalie Ives, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Bjpsych Open|February 15, 2021
Status of primary and secondary mental healthcare of people with severe mental illness: an epidemiological study from the UK PARTNERS2 programmeSiobhan Reilly, Catherine McCabe, Natalie Marchevsky, et al.
Journal of Clinical Microbiology|October 9, 2004
High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological studyPhilippa J Easterbrook, Andrea Gibson, Shahed Murad, et al.
International Journal of Language & Communication Disorders|July 10, 2025
The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related DysarthriaAvril Nicoll, Marian C Brady, Patricia Masterson-Algar, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Clinical Linguistics & Phonetics|May 1, 2019
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listenersChristina H Smith, Smitaa Patel, Rebecca L Woolley, et al.
BMJ (Clinical Research Ed.)|June 15, 2018
Self management of patients with mild COPD in primary care: randomised controlled trialKate Jolly, Manbinder S Sidhu, Catherine A Hewitt, et al.
Pilot and Feasibility Studies|January 19, 2018
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot)Catherine M Sackley, Christina H Smith, Caroline E Rick, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Trials|June 9, 2014
Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trialCatherine M Sackley, Christina H Smith, Caroline Rick, et al.
Health Technology Assessment (Winchester, England)|August 12, 2021
Practice nurse-supported weight self-management delivered within the national child immunisation programme for postnatal women: a feasibility cluster RCTAmanda J Daley, Kate Jolly, Natalie Ives, et al.
Trials|March 19, 2013
Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trialMichael Walsh, Peter A Merkel, Chen Au Peh, et al.
Bjpsych Open|February 15, 2021
Status of primary and secondary mental healthcare of people with severe mental illness: an epidemiological study from the UK PARTNERS2 programmeSiobhan Reilly, Catherine McCabe, Natalie Marchevsky, et al.
Journal of Clinical Microbiology|October 9, 2004
High rates of clustering of strains causing tuberculosis in Harare, Zimbabwe: a molecular epidemiological studyPhilippa J Easterbrook, Andrea Gibson, Shahed Murad, et al.
International Journal of Language & Communication Disorders|July 10, 2025
The PD COMM Process Evaluation: Describing Interventions and Implementation in a UK Pragmatic Randomised Controlled Trial of Speech and Language Therapy for People With Parkinson's-Related DysarthriaAvril Nicoll, Marian C Brady, Patricia Masterson-Algar, et al.
Journal of the National Cancer Institute|September 20, 2017
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant TherapyStefan Suciu, Alexander M M Eggermont, Paul Lorigan, et al.
Clinical Linguistics & Phonetics|May 1, 2019
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listenersChristina H Smith, Smitaa Patel, Rebecca L Woolley, et al.
BMJ (Clinical Research Ed.)|June 15, 2018
Self management of patients with mild COPD in primary care: randomised controlled trialKate Jolly, Manbinder S Sidhu, Catherine A Hewitt, et al.
Pilot and Feasibility Studies|January 19, 2018
Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson's disease: a pilot randomised controlled trial (PD COMM pilot)Catherine M Sackley, Christina H Smith, Caroline E Rick, et al.
Pageof 9